407.50
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $407.50, with a volume of 1.03M.
It is down -1.76% in the last 24 hours and up +7.80% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$414.78
Open:
$411.12
24h Volume:
1.03M
Relative Volume:
0.76
Market Cap:
$88.37B
Revenue:
$201.11B
Net Income/Loss:
$4.95B
P/E Ratio:
18.11
EPS:
22.4991
Net Cash Flow:
$6.29B
1W Performance:
+3.31%
1M Performance:
+7.80%
6M Performance:
+39.82%
1Y Performance:
+32.28%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health Inc
|
407.50 | 85.94B | 201.11B | 4.95B | 6.29B | 22.50 |
|
UNH
Unitedhealth Group Inc
|
397.14 | 345.44B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
96.74 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
CI
Cigna Group
|
282.52 | 72.51B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
401.54 | 45.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-26 | Initiated | Evercore ISI | In-line |
| Feb-03-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-21-25 | Downgrade | Argus | Buy → Hold |
| Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
Elevance Health stock holds after strong quarterly beat - AD HOC NEWS
Elevance Health, Inc. (ELV) Stock Analysis: Evaluating A 10% Upside Potential - DirectorsTalk Interviews
Elevance Health stock holds steady as Medicare Advantage shift and dividend set the tone - AD HOC NEWS
Health insurer Anthem targeted in lawsuit over air ambulance claims - The Republic News
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
Elevance Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
Elevance Health (NYSE: ELV) withholds 349 shares to cover EVP tax liability - Stock Titan
EVP at Elevance Health (NYSE: ELV) now holds 6,530 shares after tax withholding - Stock Titan
Elevance Health Settles Ex-Worker's Late Pay Class Claims - law360.com
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy? - TradingView
Gail Boudreaux - Britannica
Elevance Health (NYSE:ELV) Valuation Gap Persists After Rally - Kalkine Media
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Is UnitedHealth Finally Turning the Corner After a Tough 2025? - TradingView
How Is Elevance Health’s Stock Performance Compared to Other Health Providers? - Yahoo Finance
Elevance Health, Inc. $ELV Shares Bought by Northwestern Mutual Wealth Management Co. - MarketBeat
Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability - Yahoo Finance
Elevance Health (ELV): Bridging the Gap between Care and Coverage - Yahoo Finance
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Shenzhen Edge Medical Co., Ltd. Class H (HK:2675), Elevance Health (ELV) and 4DMedical Ltd (AU:4DX) - The Globe and Mail
Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 13.86% Potential Upside for Investors - DirectorsTalk Interviews
Court Lets Elevance Pursue Medicare Star Rating Bonus Claim - Bloomberg Law News
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy? - TradingView
Elevance Health, Inc. (ELV) Stock Analysis: Riding a 12.12% Potential Upside with Strong Analyst Support - DirectorsTalk Interviews
Elevance Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
$3.6M Anthem denied benefits class action settlement - Top Class Actions
Is UnitedHealth Finding a Better Path to Medicare Advantage Growth? - TradingView
Elevance Health Gets Final OK On $14.75M Nurse OT Deal - law360.com
Elevance Health stock draws fresh institutional buying as consensus targets stay above current level - Ad-hoc-news.de
Can Humana's Star Ratings Rebound Unlock MA Earnings Power? - TradingView
Venator Management LLC's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health stock trades around $400 as Q2 2026 earnings beat supports upbeat outlook - Ad-hoc-news.de
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now? - TradingView
ELV|Elevance Health Inc|Price:399.980|Chg%:+9.740 - TradingKey
Elevance Health stock holds steady as Q2 earnings beat supports 2026 outlook - Ad-hoc-news.de
Elevance Health (ELV) Dips 2.5% to $390.24 Amid Healthcare Sector UncertaintySkew Index - Vinanet
Elevance Health Inc. stock underperforms Monday when compared to competitors - MarketWatch
Elevance Health stock holds at $400 as analysts stay positive - Ad-hoc-news.de
Elevance Health, Inc. (ELV) Stock Analysis: Exploring The 12.18% Potential Upside - DirectorsTalk Interviews
State of Wyoming Takes $1.76 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Stoneridge Investment Partners LLC Acquires New Shares in Elevance Health, Inc. $ELV - MarketBeat
GSA Capital Partners LLP Buys New Holdings in Elevance Health, Inc. $ELV - MarketBeat
Family Legacy Inc. Buys New Stake in Elevance Health, Inc. $ELV - MarketBeat
Empowered Funds LLC Has $6.70 Million Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health Inc (ELV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs - TradingView
Is Elevance Health (ELV) Still A Bargain After A 38% Gain? - Yahoo Finance
Elevance Health, Inc. (ELV) latest stock news and headlines - Yahoo Finance Singapore
Western Wealth Management LLC Increases Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Can UNH's Lower Medical Costs Sustain the Earnings Recovery? - tradingview.com
Handelsbanken Fonder AB Has $30.86 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elevance Health Inc Stock (ELV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BOUDREAUX GAIL | President and CEO |
Jul 17 '26 |
Buy |
367.79 |
2,725 |
1,002,230 |
171,976 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):